Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
about
Importance of Drug Pharmacokinetics at the Site of ActionLocalized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted EffectsEGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron EmittersSubcellular Targeting of Theranostic Radionuclides
P2860
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@ast
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@en
type
label
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@ast
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@en
prefLabel
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@ast
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@en
P2093
P2860
P1476
Phase I trial to evaluate the ...... ic EGFR-positive breast cancer
@en
P2093
Anthony Brade
Curtis Caldwell
Deborah Scollard
Gina Lockwood
Jennifer Petronis
Katherine A Vallis
Kathryn Sabate
Marc Freeman
Naomi A Miller
P2860
P304
P577
2014-03-20T00:00:00Z